Blisovi Fe 1/20 Kit
Product Images NDC 68180-865

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Blisovi Fe 1/20 (NDC 68180-865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 01

Chemical structure of norethindrone acetate showing its molecular formula C22H28O3 and molecular weight 340.46. The diagram illustrates the molecular framework with functional groups and bonds.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 02

Chemical structure of ethinyl estradiol, displaying its molecular formula C20H24O2 and a molecular weight of 296.40.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 03

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It compares mortality rates across four age groups (15-24, 25-34, 35-44, 45+), with distinct bars representing ever-users and controls among smokers and non-smokers. Mortality rates increase notably with age, especially for smokers who are ever-users.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 04

A forest plot chart depicting effect estimates from multiple studies comparing contraceptive use versus non-use. The chart lists 8 studies with corresponding odds ratios (OR), relative risks (RR), and hazard ratios (HR) alongside horizontal lines showing confidence intervals. The x-axis is labeled 'Effect Estimate' ranging from -1.50 to 2.00 with a central vertical line at 1.00, indicating the null effect.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 05

An instructional diagram for BLISOVI FE 1/20 showing a 28-day pill pack layout. Days of the week are arranged in rows for Weeks 1 to 4 with circles representing pill slots. Arrows indicate the sequence for pill intake. Instructions guide users to start on Sunday or place a day label strip for day-1 starters, along with a note for monthly self-breast exams.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 06

An instructional diagram for BLISOVI FE 1/20 showing a weekly pill schedule grid labeled by days of the week (Sunday to Saturday) and four weeks. It includes arrows indicating the sequence of pill intake and instructions for day-1 starters versus Sunday starters, with a reminder for monthly self breast exam on the right side.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 07

Blisovi Fe 1/20 tablets lidding foil and blister card showing norethindrone acetate and ethinyl estradiol 1 mg/0.02 mg per tablet. Distributed by Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and manufactured by Lupin Limited, India. The foil includes storage instructions and barcode. The blister card is arranged in a 28-day cycle labeled by day of week and week, indicating daily tablet placement and a monthly self breast exam reminder.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 08

Label for Blisovi Fe 1/20 tablets containing norethindrone acetate and ethinyl estradiol with ferrous fumarate tablets, dosed at 1 mg/0.02 mg. The label indicates 1 blister pack of 28 tablets, distributed by Lupin Pharmaceuticals, Inc. The design uses a green and yellow background with product warnings and dosage instructions.*

FDA Label Image

80ca76da 51ef 499f 988a 4ded69035439 09

Packaging label for Blisovi Fe 1/20 tablets containing 1 mg norethindrone acetate, 0.02 mg ethinyl estradiol, and ferrous fumarate. The label indicates it is a prescription product distributed by Lupin Pharmaceuticals, Inc., and comes in 3 blisters of 28 tablets each. The label features green and yellow colors and includes barcodes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.